Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Distribution of CM500 in Healthy Volunteers and Patients With Cancer

NCT07781852 is registered in ClinicalTrials.gov with Lumina Pharmaceuticals Inc as lead sponsor.

NCT NCT07781852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07781852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Distribution of CM500 in Healthy Volunteers and Patients With Cancer
Lead sponsor
Lumina Pharmaceuticals Inc
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2027
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, breast cancer, colorectal cancer, esophageal cancer, gastric cancer (gc), glioblastoma (gbm), glioma, kidney cancer, liver cancer, lung cancer (nsclc), oral cavity cancer, ovarian cancer, pancreatic cancer, pdac - pancreatic ductal adenocarcinoma, pharynx cancer, prostate cancer